Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-06 Sale | 2026-01-07 4:30 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 3,925 | $1.11 | $4,357 | 88,273 (Direct) | View |
| 2025-09-16 Purchase | 2025-09-18 4:23 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 92,233 | $1.0772 | $99,352 | 305,121 (Direct) | View |
| 2025-08-18 Purchase | 2025-08-20 4:02 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer | 75,000 | $0.7787 | $58,402 | 75,000 (Direct) | View |
| 2025-08-15 Sale | 2025-08-19 4:12 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 611 | $0.6404 | $391 | 89,198 (Direct) | View |
| 2025-08-15 Sale | 2025-08-19 4:09 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 2,382 | $0.6404 | $1,525 | 212,888 (Direct) | View |
| 2025-07-07 Sale | 2025-07-08 4:37 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 2,011 | $0.4501 | $905 | 86,809 (Direct) | View |
| 2025-06-30 Sale | 2025-07-01 4:22 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 1,532 | $0.43 | $659 | 88,820 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:25 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 550 | $1.1502 | $633 | 87,352 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:23 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Pons Jaume PRESIDENT & CSO | 1,326 | $1.1502 | $1,525 | 579,388 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 4:20 pm | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 2,159 | $1.1502 | $2,483 | 170,270 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-26 Option Award | 2026-01-28 4:30 pm | N/A 2036-01-25 | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer | 303,000 | $0 | 303,000 (Direct) | View |
| 2026-01-26 Option Award | 2026-01-28 4:30 pm | N/A 2036-01-25 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 192,000 | $0 | 192,000 (Direct) | View |
| 2026-01-26 Option Award | 2026-01-28 4:30 pm | N/A 2036-01-25 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 912,000 | $0 | 912,000 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-21 4:30 pm | N/A 2036-01-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | GOODMAN COREY S Director 10% Owner | 40,400 | $0 | 40,400 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-21 4:30 pm | N/A 2036-01-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Garland J. Scott Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-21 4:30 pm | N/A 2036-01-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Director | 10,100 | $0 | 10,100 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-21 4:30 pm | N/A 2036-01-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Curran Daniel J. Director | 16,833 | $0 | 16,833 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-21 4:30 pm | N/A 2036-01-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Takimoto Chris H Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-21 4:30 pm | N/A 2036-01-19 | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-10-14 Option Award | 2025-10-16 4:01 pm | N/A 2035-10-14 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 140,000 | $0 | 140,000 (Direct) | View |
| 2025-10-14 Option Award | 2025-10-16 4:01 pm | N/A 2035-10-14 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 597,500 | $0 | 597,500 (Direct) | View |
| 2025-10-14 Option Award | 2025-10-16 4:01 pm | N/A 2035-10-14 | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer | 198,750 | $0 | 198,750 (Direct) | View |
| 2025-09-17 Option Award | 2025-09-19 4:01 pm | N/A 2035-09-16 | ALX ONCOLOGY HOLDINGS INC | ALXO | Klencke Barbara Director | 300,000 | $0 | 300,000 (Direct) | View |
| 2025-08-12 Option Award | 2025-08-13 4:47 pm | N/A 2035-08-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Curran Daniel J. Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-04-11 Option Award | 2025-04-15 4:29 pm | N/A 2035-04-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 90,000 | $0 | 90,000 (Direct) | View |
| 2025-04-11 Option Award | 2025-04-15 4:19 pm | N/A 2035-04-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Chief Medical Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2025-04-11 Option Award | 2025-04-15 4:16 pm | N/A 2035-04-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2025-04-11 Option Award | 2025-04-15 4:14 pm | N/A 2035-04-11 | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 125,000 | $0 | 125,000 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 4:45 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Pinto Shelly SVP, FINANCE AND CAO | 3,000 | $0 | 90,352 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 4:41 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Lettmann Jason CHIEF EXECUTIVE OFFICER | 42,000 | $0 | 212,270 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:32 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Hemrajani Rekha Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:30 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Garland J. Scott Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:29 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | GOODMAN COREY S Director 10% Owner | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:27 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Takimoto Chris H Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:24 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Klencke Barbara Director | 40,400 | $0 | 40,400 (Direct) | View |
Ownership | 2025-01-23 6:22 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | Klencke Barbara Director | 0 | $0 | 120,000 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 6:19 pm | N/A 2035-01-20 | ALX ONCOLOGY HOLDINGS INC | ALXO | Shantharam Harish Chief Financial Officer | 600,000 | $0 | 600,000 (Direct) | View |